Let's answer the question most people ask quietly: does anyone actually help pay for this?The honest 2026 answer: not as much as it should, but more than you'd think.

Health insurance: the current state

Most Indian retail health-insurance policies do not cover GLP-1 medications for weight management. That's because obesity is typically classified as a “lifestyle condition” in standard policy wording — same bucket as cosmetic dermatology.

However, here's where it gets nuanced:

  • If you have type 2 diabetesdiagnosed and are prescribed semaglutide or tirzepatide for diabetes (under its T2DM indication, not the weight indication), reimbursement is often possible — especially with public-sector insurers (PSUs) and group-corporate policies. You file claims under the diabetes treatment line.
  • If you have a documented metabolic comorbidity that the policy covers (e.g. fatty liver disease, severe sleep apnoea), some insurers approve GLP-1 as part of treatment for that condition.
  • Bariatric-surgery riders (rare, but increasingly available) often include GLP-1 as a pre-surgery weight-reduction step.

The practical advice: ask your insurer in writing, citing your diabetes / comorbidity diagnosis. Approvals are inconsistent across insurers; we've seen the same diagnosis reimbursed by one and denied by another.

GST: 12% on medication, 18% on consultations

Prescription medications, including GLP-1, attract 12% GST. We include this in the listed price — what you see is what you pay.

Doctor consultations are technically exempt from GST when the consultation itself is the service. When bundled with other taxable services (delivery, app subscription, etc.), the bundled price attracts 18% GST on the non-consultation portion.

For most ZIVOLABS patients on a subscription plan, the effective GST works out to about 13–14% of the monthly cost.

Section 80DDB and chronic-illness benefits

Under Section 80DDB of the Income Tax Act, expenses for the treatment of specified chronic diseases (including type 2 diabetes when severe / insulin-dependent) qualify for a deduction of up to ₹40,000 per year(₹1,00,000 for senior citizens). This requires a certificate from a specialist physician.

If you're using GLP-1 for diabetes and you meet the criteria, your treating doctor can issue the certificate as part of your consultation paperwork. You apply it to your tax return.

Corporate cafeteria / FSA / wellness reimbursement

Many large Indian employers now have wellness allowances:

  • Medical reimbursement quotasas part of CTC structure — typically ₹15,000–₹60,000 per year. GLP-1 consultation + medication invoices are reimbursable.
  • Corporate wellness programmes with partner networks; some now include weight-management as an explicit line item. Worth asking HR.
  • Group insurance riders: increasingly common to add chronic-disease management coverage on group policies for employees with diabetes. Speak to your insurance contact.

The cheapest legitimate way to pay

For most patients, the cheapest legitimate path is:

  1. Subscription planthat bundles consultation + medication + check-ins — about 15–20% cheaper than buying each piece separately.
  2. Use your employer's medical reimbursementquota for the year. ₹30,000–₹60,000 typically covers 3–6 months of treatment.
  3. Claim 80DDBif you have diabetes plus an eligible certificate — saves up to ₹12,000 in tax at the highest slab.
  4. For longer commitments, consider quarterly bundled payment — we offer 5% off when patients pay for three months at a time, which adds up.

Avoid: 'cheap GLP-1' from unverified sources

You'll find online sellers advertising semaglutide and tirzepatide at fractions of the legitimate price. Don't.These are unlicensed, often counterfeit, and the supply chain is not temperature-controlled.

The cheaper-looking ₹3,000-per-month vial is either expired stock, a different molecule entirely, or research-grade peptide that was never meant for human use. Two patients in Bengaluru and Hyderabad died in 2025 from contaminated grey-market semaglutide. This is not a place to economise.

The simple summary

For most Indian patients:

  • Expect ₹7,000–₹19,500/month out of pocket on a doctor-supervised plan, all-inclusive.
  • Insurance helps if you're prescribed for diabetes.
  • Employer medical reimbursement is the most common reliable offset.
  • Tax deduction under 80DDB is worth investigating with your CA.
  • Never compromise on the source of medication to save money.